These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33945464)

  • 1. Suicide Attempt in a Patient with Sibutramine Associated Psychosis.
    Câmara Pestana P; Ferreira C; Santos AL; Jerónimo J; Ganança L
    Acta Med Port; 2022 Mar; 35(3):216-218. PubMed ID: 33945464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation.
    Lee J; Teoh T; Lee TS
    J Psychosom Res; 2008 Jan; 64(1):107-9. PubMed ID: 18158006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sibutramine-associated psychosis (case report).
    Gazdag G; Szabó Z
    Neuropsychopharmacol Hung; 2008 May; 10(2):107-10. PubMed ID: 18959143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sibutramine-associated psychotic symptoms and zolpidem-induced complex behaviours: implications for patient safety.
    Wiglusz MS; Cubała WJ; Nowak P; Jakuszkowiak-Wojten K; Landowski J; Krysta K
    Psychiatr Danub; 2013 Sep; 25 Suppl 2():S143-5. PubMed ID: 23995163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicide attempts by jumping and psychotic illness.
    Nielssen O; Glozier N; Babidge N; Reutens S; Andrews D; Gerard A; Malhi GS; Large MM
    Aust N Z J Psychiatry; 2010 Jun; 44(6):568-73. PubMed ID: 20482416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.
    Henderson DC; Copeland PM; Daley TB; Borba CP; Cather C; Nguyen DD; Louie PM; Evins AE; Freudenreich O; Hayden D; Goff DC
    Am J Psychiatry; 2005 May; 162(5):954-62. PubMed ID: 15863798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Life-threatening psychosis caused by using sibutramine-contaminated weight-loss coffee].
    Bertholee D; ter Horst PG; Wieringa A; Smit JP
    Ned Tijdschr Geneeskd; 2013; 157(51):A6676. PubMed ID: 24345358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of sibutramine.
    Ryan DH
    Drugs Today (Barc); 2004 Jan; 40(1):41-54. PubMed ID: 14988769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sibutramine-induced mania as the first manifestation of bipolar disorder.
    Waszkiewicz N; Zalewska-Szajda B; Szajda SD; Simonienko K; Zalewska A; Szulc A; Ładny JR; Zwierz K
    BMC Psychiatry; 2012 May; 12():43. PubMed ID: 22607132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study.
    Milano W; Petrella C; Casella A; Capasso A; Carrino S; Milano L
    Adv Ther; 2005; 22(1):25-31. PubMed ID: 15943219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosis associated with usage of herbal slimming products adulterated with sibutramine: a case series.
    Chen SP; Tang MH; Ng SW; Poon WT; Chan AY; Mak TW
    Clin Toxicol (Phila); 2010 Oct; 48(8):832-8. PubMed ID: 20969504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akathisia: a life-threatening side effect of a common medication.
    Cheng HM; Park JH; Hernstadt D
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23697447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myocardial infarction in a 24 year-old man possibly associated with sibutramine use.
    Eroglu E; Gemici G; Bayrak F; Kalkan AK; Degertekin M
    Int J Cardiol; 2009 Oct; 137(2):e43-5. PubMed ID: 18687492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials.
    Jordan J; Scholze J; Matiba B; Wirth A; Hauner H; Sharma AM
    Int J Obes (Lond); 2005 May; 29(5):509-16. PubMed ID: 15685250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of antipsychotic medication and suicidality--the Northern Finland Birth Cohort 1966.
    Rissanen I; Jääskeläinen E; Isohanni M; Koponen H; Joukamaa M; Alaräisänen A; Miettunen J
    Hum Psychopharmacol; 2012 Sep; 27(5):476-85. PubMed ID: 22886816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A benefit-risk assessment of sibutramine in the management of obesity.
    Nisoli E; Carruba MO
    Drug Saf; 2003; 26(14):1027-48. PubMed ID: 14583064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent episodes of brief affective psychosis induced by sibutramine.
    Naik S; Khoo CL; Lua R; Chai SB; Liew A; Sim K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1359-60. PubMed ID: 20643178
    [No Abstract]   [Full Text] [Related]  

  • 20. Sibutramine-associated psychotic episode.
    Taflinski T; Chojnacka J
    Am J Psychiatry; 2000 Dec; 157(12):2057-8. PubMed ID: 11097984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.